Providing expert due diligence for the reformulation of a marketed biologic
Challenge
An established European pharma company needed an opportunity assessment for a reformulation of a marketed biologic.
Solution
We quantified the market opportunity and assessed the market positioning and unique selling propositions (USPs) of the target product. We also reviewed the competitive environment, assessing sales and pricing of competitor products (based on IMS data) and likely competitive responses from established players in the market.
Related Case Studies
Explore similar engagements and see how we've helped other clients achieve their goals.
Evaluating the Commercial Viability of a Novel Neonatal Therapy Approach
Challenge: A leading U.S. children’s hospital commissioned an independent review of a novel therapeutic approach for rare neonatal diseases. The principal investigator (PI) - a...
Landscape Assessment of Novel Pain Targets for R&D Prioritization
Challenge: A privately held US-based biotech company specializing in pain therapeutics had developed a cutting-edge drug discovery platform utilizing multi-omic, tissue-specific...
Clinical landscape analysis for Tumor Infiltrating Lymphocytes
Challenge A European investor was refocusing its investment efforts and considering targeting the oncology cell therapy space. It had a particular interest in tumor infiltrating...
Primary market research and patient segmentation mapping in myelofibrosis
Challenge: A venture-backed US biotech company was developing a preclinical biologic for haematological indications and wished to quantify the commercial opportunity for the...
Interested in Learning More?
Contact us to discuss how we can support your project with similar expertise.